Keyur Patel Selected Research

Peptide Hydrolases (Proteases)

1/2022	An MMP-degraded and cross-linked fragment of type III collagen as a non-invasive biomarker of hepatic fibrosis resolution.
2/2021	Efficacy and safety of a porcine peritoneum-derived matrix in diabetic foot ulcer treatment: a pilot study.
1/2021	Evaluation of the combination of a biofilm-disrupting agent and negative pressure wound therapy: a case series.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Keyur Patel Research Topics

Disease

49	Fibrosis (Cirrhosis) 03/2024 - 03/2002
42	Chronic Hepatitis C 01/2020 - 03/2002
34	Infections 01/2023 - 03/2002
25	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2023 - 01/2013
20	Neoplasms (Cancer) 03/2024 - 05/2013
16	Liver Cirrhosis (Hepatic Cirrhosis) 03/2024 - 03/2003
16	Non-alcoholic Fatty Liver Disease 03/2024 - 05/2010
16	Hepatitis C 01/2019 - 11/2002
10	Liver Diseases (Liver Disease) 03/2024 - 01/2006
9	Wounds and Injuries (Trauma) 12/2023 - 10/2016
9	Inflammation (Inflammations) 01/2022 - 03/2002
8	Hepatocellular Carcinoma (Hepatoma) 11/2023 - 05/2006
8	Disease Progression 12/2016 - 11/2002
6	Anemia 01/2022 - 11/2003
6	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2021 - 11/2015
6	Insulin Resistance 01/2019 - 10/2009
5	End Stage Liver Disease 06/2023 - 08/2008
5	Philadelphia Chromosome 01/2023 - 03/2017
5	Virus Diseases (Viral Diseases) 08/2012 - 02/2004
4	Alcoholic Fatty Liver 01/2023 - 01/2022
4	Chromosome Aberrations (Chromosome Abnormalities) 11/2022 - 03/2017
4	Hemolytic Anemia 02/2014 - 10/2010
3	Hepatitis 03/2024 - 01/2018
3	Hypertension (High Blood Pressure) 01/2023 - 09/2017
3	Pruritus (Itching) 01/2023 - 01/2020
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2022 - 11/2017
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2021 - 01/2019
3	Autoimmune Diseases (Autoimmune Disease) 09/2021 - 01/2006
3	Ulcer 05/2021 - 02/2021
3	Tuberous Sclerosis (Bourneville's Disease) 10/2017 - 11/2016
3	Inborn Genetic Diseases (Disease, Hereditary) 10/2017 - 11/2016
3	Residual Neoplasm 04/2017 - 01/2016
3	Body Weight (Weight, Body) 05/2013 - 03/2002
2	Portal Hypertension 03/2024 - 08/2008
2	Obesity 11/2023 - 01/2022
2	Cicatrix (Scar) 06/2023 - 01/2019
2	Chronic Hepatitis B 01/2023 - 07/2017
2	Pain (Aches) 01/2023 - 05/2021
2	Sclerosing Cholangitis 01/2023 - 01/2023
2	Leukocytosis (Pleocytosis) 01/2022 - 01/2017

Drug/Important Bio-Agent (IBA)

26	Biomarkers (Surrogate Marker)IBA 03/2024 - 12/2004
22	Ribavirin (Virazole)FDA LinkGeneric 01/2020 - 03/2002
19	Antiviral Agents (Antivirals)IBA 02/2024 - 10/2002
17	InterferonsIBA 01/2019 - 03/2002
11	Proteins (Proteins, Gene)FDA Link 06/2023 - 12/2004
11	Alanine Transaminase (SGPT)IBA 01/2023 - 03/2002
8	RNA (Ribonucleic Acid)IBA 05/2013 - 03/2002
6	Interferon-alpha (Interferon Alfa)IBA 02/2012 - 05/2004
5	venetoclaxIBA 11/2023 - 01/2019
5	SofosbuvirIBA 01/2020 - 05/2013
4	Hepatitis B e AntigensIBA 02/2024 - 01/2020
4	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 01/2018
4	Complement C3 (C3 Complement)IBA 06/2023 - 02/2015
4	BilirubinIBA 06/2023 - 09/2018
4	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023 - 01/2021
4	Core Binding Factors (Core-Binding Factor)IBA 11/2022 - 10/2014
4	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2022 - 10/2014
4	farglitazarIBA 01/2022 - 04/2010
4	Sorafenib (BAY 43-9006)FDA Link 01/2020 - 01/2018
4	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2016
4	CytokinesIBA 11/2018 - 06/2006
4	LipidsIBA 12/2016 - 06/2010
4	Inosine TriphosphataseIBA 02/2014 - 10/2010
3	NucleophosminIBA 01/2023 - 11/2016
3	CreatinineIBA 01/2023 - 01/2022
3	cilofexorIBA 01/2023 - 01/2020
3	Gemtuzumab (Mylotarg)FDA Link 11/2022 - 10/2014
3	fludarabineIBA 11/2022 - 10/2014
3	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 01/2021
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 01/2016
3	ImmunosorbentsIBA 01/2022 - 10/2009
3	Collagen Type III (Type III Collagen)IBA 01/2022 - 02/2015
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2021 - 01/2016
3	ibrutinibIBA 12/2021 - 01/2019
3	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2020 - 10/2010
3	Janus Kinase 2IBA 01/2019 - 05/2013
3	ruxolitinibIBA 01/2018 - 05/2013
3	trans-sodium crocetinate (crocetin)IBA 10/2017 - 11/2016
3	fms-Like Tyrosine Kinase 3IBA 04/2017 - 01/2016
3	Peptides (Polypeptides)IBA 02/2015 - 02/2006
3	Hyaluronic Acid (Hyaluronan)IBA 12/2014 - 03/2003
3	Pregnancy-Associated alpha 2-Macroglobulins (alpha 2 Macroglobulin)IBA 12/2014 - 12/2004
3	CholesterolIBA 07/2012 - 06/2010
3	Interferon LambdaIBA 12/2010 - 06/2010
2	Rituximab (Mabthera)FDA Link 05/2024 - 12/2021
2	Immune Checkpoint InhibitorsIBA 06/2023 - 01/2023
2	AlbuminsIBA 06/2023 - 07/2007
2	blinatumomabIBA 01/2023 - 10/2021
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2023 - 04/2014
2	Tenofovir (Viread)FDA Link 01/2023 - 01/2016
2	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 11/2022 - 01/2017
2	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 09/2017

Therapy/Procedure

70	Therapeutics 04/2024 - 03/2002
17	Liver Transplantation 11/2023 - 07/2005
14	Drug Therapy (Chemotherapy) 01/2022 - 08/2013
4	Transplantation 01/2023 - 01/2017
3	Immunotherapy 01/2023 - 01/2017
3	Precision Medicine 12/2021 - 04/2014
3	Aftercare (After-Treatment) 01/2021 - 03/2003
3	Stem Cell Transplantation 07/2020 - 01/2016